PBM Act
Summary
The PBM Act (HR8779) would prohibit common ownership of pharmacy benefit managers and pharmacies, directly threatening the integrated business models of UnitedHealth, CVS Health, and Cigna. Although in early legislative stages, bipartisan sponsorship signals potential momentum.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.If passed, the bill forces divestitures of PBM or pharmacy assets from major integrated healthcare firms.
- 2.UnitedHealth, CVS Health, and Cigna face the highest structural and revenue risk.
- 3.Market pricing of this risk remains low due to early legislative stage; monitor committee activity.
Market Implications
The PBM Act introduces regulatory risk for the largest healthcare conglomerates. Currently, the market has not priced in this risk given the bill's early stage. If the bill gains traction—e.g., committee markup or bipartisan support grows—expect pressure on UNH, CVS, and CI as investors reassess the value of vertical integration. Conversely, independent pharmacies and PBM-focused companies without pharmacy ties could see relative benefit, but no such public companies are clearly isolated.
Full Analysis
The Patients Before Monopolies Act (PBM Act) was introduced on May 13, 2026, and referred to the House Committee on the Judiciary. It targets vertical integration in healthcare by barring PBMs and pharmacies from being under common ownership. The bill cites FTC findings that integrated PBMs steer patients to affiliated pharmacies, reducing competition and raising costs. No appropriation is involved; the bill imposes a structural prohibition. If enacted, UnitedHealth (UNH) would likely need to divest either OptumRx (PBM) or its Optum pharmacy network. CVS Health (CVS) would face a similar choice between Caremark (PBM) and CVS Pharmacy. Cigna (CI), through Express Scripts, would also be forced to spin off its PBM or exit pharmacy operations. Independent pharmacies could benefit from reduced self-preferencing, but no pure-play pharmacy tickers meet the causal chain threshold. The bill is early stage—only referred to committee—but has bipartisan sponsorship (7 cosponsors including both Republicans and Democrats). The legislative path requires committee markup, House passage, Senate consideration, and presidential action. Given the 119th Congress runs through 2027, there is time for development, but no immediate market impact is expected.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Prohibition of common ownership between PBM and pharmacy operations
Who must act
CVS Health (owns Caremark PBM and CVS Pharmacy retail chain)
What happens
Must divest either Caremark or CVS Pharmacy, disrupting integrated health services strategy and reducing profit from pharmacy benefit management
Stock impact
Caremark PBM and retail pharmacy together represent ~70% of CVS's revenue; forced separation would eliminate cross-segment efficiencies and potentially lower margins
What the bill does
Prohibition of common ownership between PBM and pharmacy operations
Who must act
Cigna (owns Express Scripts PBM and has pharmacy partnerships via Evernorth)
What happens
Must divest Express Scripts or exit pharmacy-related businesses, eliminating a key profit center and reducing bargaining power with drug manufacturers
Stock impact
Express Scripts accounts for ~60% of Cigna's total revenue; divestiture would remove the primary growth driver and lower EBITDA margins significantly
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
PBM Act
A bill to amend title 10, United States Code, to improve access to certain medications under the TRICARE program, and for other purposes.
Pharmacists Fight Back in Medicare and Medicaid Act
Protecting Pharmacies in Medicaid Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Women's Health to Improve Outcomes in All Phases of Life
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →